E. Nadal

发表

Imatinib mesylate (Gleevec/Glivec) a molecular‐targeted therapy for chronic myeloid leukaemia and other malignancies

E. Nadal, E. Olavarría, 2004, International journal of clinical practice.

Smoldering multiple myeloma: natural history and recognition of an evolving type

E. Giné, S. Montoto, J. Esteve, 2003, British journal of haematology.

Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance

E. Giné, S. Montoto, F. Bosch, 2002, British journal of haematology.

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy

D. Marin, J. Goldman, M. Bua, 2007, Leukemia.

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission

E. Giné, J. Esteve, E. Montserrat, 2004, Bone Marrow Transplantation.

Malignant transformation in IgM monoclonal gammopathy of undetermined significance.

E. Giné, A. López-Guillermo, S. Montoto, 2003, Seminars in oncology.

T-cell receptor repertoire usage after allografting differs between CD 4 + CD 25 + regulatory T cells and their CD 4 + CD 25 – counterpart

F. Dazzi, C. Fozza, M. Longinotti, 2007 .

Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib.

T. Vulliamy, D. Marin, J. Goldman, 2004, Leukemia research.

Primary follicular lymphoma arising in the ampulla of Vater

A. López-Guillermo, E. Campo, A. Martínez, 2002, Annals of Hematology.

Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

J. Goldman, F. Dazzi, C. Fozza, 2007, British journal of haematology.

Limitations of Gallium‐67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome

F. Bosch, J. Esteve, E. Campo, 2002, British journal of haematology.

Danazol treatment of idiopathic myelofibrosis with severe anemia.

E. Montserrat, F. Cervantes, J. Hernández-Boluda, 2000, Haematologica.

Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood

E. Montserrat, M. Aymerich, D. Colomer, 2003, Leukemia.

Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

R. Lechler, F. Dazzi, J. Apperley, 2007, Leukemia.

Hypercalcemia as the Presenting Feature of T-Cell Lymphoid Blast Crisis of Ph-Positive Chronic Myeloid Leukemia

E. Montserrat, L. Rosiñol, F. Cervantes, 2001, Leukemia & lymphoma.

T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25- counterpart.

F. Dazzi, C. Fozza, M. Longinotti, 2007, Haematologica.

Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions.

J. Goldman, F. Dazzi, J. Apperley, 2004, Experimental hematology.

33: Increased CD4+CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)

R. Lechler, F. Dazzi, J. Apperley, 2007 .

Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma

J. Goldman, A. Rahemtulla, J. Apperley, 2004, Leukemia.